Kahan Bd
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments 50
-
- Pharmacological Effects and Toxicity Studies 20
- Pharmacy top 10%
- Oral and gingival health research 10
-
- Transplantation: Methods and Outcomes 18
- Organ Transplantation Techniques and Outcomes 15
-
- Metabolism and Genetic Disorders 8
-
- Neurological Complications and Syndromes 7
-
- Cytomegalovirus and herpesvirus research 7
- Co-authors
- Van Buren CtH. YamagishiJoachim GrevelSilvana SavoldiCamilo G. BarcenasT HamashimaFrazier OhS. Flechner
- Journals
- Transplantation Proceedings (4 papers)PubMed (81 papers)
- Partner nations
- United States
In The Last Decade
Kahan Bd
82 papers receiving 629 citations
Peers
Comparison fields: 5 of 81
- Transplantation 272
- Immunology 117
- Pediatrics, Perinatology and Child Health 106
- Pharmacy 26
- Hepatology 36
Countries citing papers authored by Kahan Bd
This map shows the geographic impact of Kahan Bd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kahan Bd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kahan Bd more than expected).
Fields of papers citing papers by Kahan Bd
This network shows the impact of papers produced by Kahan Bd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kahan Bd. The network helps show where Kahan Bd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kahan Bd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Concentration-controlled immunosuppressive regimens using cyclosporine with sirolimus or brequinar in human renal transplantation. | 1995 | 8 |
| 2 | Synergistic effects of cyclosporin analogs--A, D, G, IMM-125--with rapamycin and/or brequinar. | 1994 | 5 |
| 3 | New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation. | 1994 | 4 |
| 4 | Stability of renal allograft glomerular filtration rate in the cyclosporine era: 2-year follow-up. | 1994 | 1 |
| 5 | Steady-state concentrations of cyclosporine for therapeutic monitoring. | 1990 | 4 |
| 6 | Intravenous administration of cyclosporine for immunosuppression in heart transplant patients. | 1989 | 1 |
| 7 | Pharmacokinetics and pharmacodynamics of cyclosporine. | 1989 | 12 |
| 8 | Clinical outcome in 36 patients after at least one and up to 5 years of steroid withdrawal based upon specific mixed lymphocyte reaction hyporesponsiveness toward the living related donor. | 1989 | 13 |
| 9 | Comparison and correlation of assays for monitoring cyclosporine drug levels in renal transplant recipients. | 1988 | 5 |
| 10 | The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine. | 1988 | 3 |
| 11 | Effects of cyclosporine on nuclear function. | 1988 | 1 |
| 12 | Impact of a combined regimen of cyclosporine and 3M KCl extracted histocompatibility antigen on heterotopic rat cardiac allograft survival. | 1988 | 1 |
| 13 | Management of immunosuppressive problems in renal allograft recipients. | 1987 | 1 |
| 14 | Investigation of human T-lymphotropic virus III serology in a renal transplant population. | 1987 | 6 |
| 15 | Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases. | 1986 | 6 |
| 16 | The case against conversion to azathioprine in cyclosporine-treated renal recipients. | 1985 | 22 |
| 17 | Cardiac transplantation at the Texas Heart Institute: recent experience. | 1985 | 1 |
| 18 | Management of end-stage renal disease by transplantation: the use and limitations of cyclosporine. | 1985 | 1 |
| 19 | Effect of splenectomy upon tumor growth: characterization of splenic tumor-enhancing cells in vivo. | 1980 | 23 |
| 20 | Advances in the chemistry of transplantation antigens. | 1969 | 9 |
About Kahan Bd
Kahan Bd is a scholar working on Transplantation, Pharmacy, Clinical Biochemistry, Pediatrics, Perinatology and Child Health and Surgery, having authored 85 papers that have together received 670 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (50 papers), Pharmacological Effects and Toxicity Studies (20 papers), Transplantation: Methods and Outcomes (18 papers), Organ Transplantation Techniques and Outcomes (15 papers), Oral and gingival health research (10 papers), Metabolism and Genetic Disorders (8 papers), Neurological Complications and Syndromes (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). The work is most often cited by research in Transplantation (272 citations), Immunology (117 citations), Pediatrics, Perinatology and Child Health (106 citations), Pharmacy (26 citations) and Hepatology (36 citations). Kahan Bd has collaborated with scholars based in United States. Frequent co-authors include Van Buren Ct, H. Yamagishi, Joachim Grevel, Silvana Savoldi, Camilo G. Barcenas, T Hamashima, Frazier Oh, S. Flechner, Ronald H. Kerman and Pierre Daloze. Their work appears in journals such as Transplantation Proceedings and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.